Track Shuttle Pharmaceuticals Holdings Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Shuttle Pharmaceuticals Holdings Inc. Common Stock SHPH · Stock Open Shuttle Pharmaceuticals Holdings Inc. Common Stock in new tab

3.50 USD
Add to portfolio
P/E
35.89
EPS
0.10
P/B
0.60
ROE
-326.36
Beta
1.22
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
P/E35.89
EPS0.10
Book Value6.03
Price to Book0.60
Debt/Equity6.40
% Insiders3.905%

DCF Valuation

Tweak assumptions to recompute fair value for Shuttle Pharmaceuticals Holdings Inc. Common Stock (SHPH)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Shuttle Pharmaceuticals Holdings Inc. Common Stock Logo Shuttle Pharmaceuticals Holdings Inc. Common Stock Analysis (SHPH)

United States Health Care Official Website Stock

Is Shuttle Pharmaceuticals Holdings Inc. Common Stock a good investment? Shuttle Pharmaceuticals Holdings Inc. Common Stock (SHPH) is currently trading at 3.50 USD.

In terms of valuation, the stock trades at a P/E ratio of 35.89. This high multiple suggests investors have priced in significant future growth expectations.

Investor FAQ

Does Shuttle Pharmaceuticals Holdings Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Shuttle Pharmaceuticals Holdings Inc. Common Stock?

Shuttle Pharmaceuticals Holdings Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Exchange Ticker
NMS (United States) SHPH
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Aug. 13, 2024 Needs review
June 16, 2025 1:25
June 11, 2026 1:10
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion